Postępy w Kardiologii Interwencyjnej

Inflammatory burden index and contrast-associated acute kidney injury after iliac artery endovascular intervention: association with renal injury and lesion complexity

Mustafa Ferhat Keten 1
,
Kadir Biyikli 1
,
Busra Guvendi Sengor 1
,
Seda Tanyeri Uzel 1
,
Mustafa Furkan Kılıçarslan 1
,
Ayşe Nur Küçük 1
,
Hasan Karaot 1
,
Azmican Kaya 1
,
Nesri Danısman 1
,
Ismail Balaban 1

  1. Department of Cardiology, Kartal Koşuyolu High Specialization Training and Research Hospital, Istanbul, Turkey

Adv Interv Cardiol

DOI: https://doi.org/10.5114/aic.2026.164982
Data publikacji online: 2026/09/22
Article files
Inflammatory burden index.pdf Inflammatory burden index - supplementary material.pdf
  1. Mazzolai L, Teixido-Tura G, Lanzi S, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J 2024; 45: 3538-700.
  2. Yang M, Zhang B, Niu G, et al. Long-term results of endovascular reconstruction for aortoiliac occlusive disease. Quant Imaging Med Surg 2021; 11: 1303-12.
  3. Zuo T, Jiang L, Mao S, et al. Hyperuricemia and contrast-induced acute kidney injury: a systematic review and meta-analysis. Int J Cardiol 2016; 224: 286-94.
  4. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-5.
  5. Nemoto M, Matsuura S, Sakurai Y, et al. Contrast-induced nephropathy. Ann Vasc Dis 2026; 19: ra.26-00063.
  6. Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med 2019; 380: 2146-55.
  7. Önal Ç, Yıldız C, Yüksel Y, et al. Predictive performance of the aggregate index of systemic inflammation for contrast-induced nephropathy after PCI in elderly ACS patients. Medicina 2026; 62: 361.
  8. Tian G, Qian C, Liu Z, et al. Association of triglyceride-glucose index and high-sensitivity C-reactive protein with contrast-induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome: a retrospective cohort study. Front Cardiovasc Med 2026; 13: 1733377.
  9. AlHammouri HM, Mustafa O, Mash’al N, et al. Inflammatory markers and contrast-induced nephropathy risk: a meta-analysis of NLR and PLR in ACS patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2025; 106: 2361-73.
  10. Bağcı A, Aksoy F, Baş HA. Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with st-segment elevation myocardial infarction. Angiology 2022; 73: 218-24.
  11. Karaduman A, Yılmaz C, Keten MF, et al. Prognostic value of nutrition for contrast-induced nephropathy in patients undergoing peripheral vascular intervention. Biomark Med 2024; 18: 801-11.
  12. Xie H, Ruan G, Ge Y, et al. Inflammatory burden as a prognostic biomarker for cancer. Clin Nutr 2022; 41: 1236-43.
  13. Yun LX, Huang WZ, He C, et al. Association between inflammatory burden index and risk of heart failure: evidence from NHANES 2003–2017. BMC Cardiovasc Disord 2025; 25: 318.
  14. Tao Y, Liu W, Yin J, et al. Inflammatory Burden Index is associated with increased long-term risk of major adverse cardiovascular events in myocardial infarction with non-obstructive coronary arteries. Int J Gen Med 2026; 19: 572612.
  15. Osmanaj F, Zhou M, Hua K, et al. Preoperative Inflammatory Burden Index predicts atrial fibrillation after coronary artery bypass grafting: a retrospective cohort study. J Clin Med 2026; 15: 1246.
  16. Jiang K, Jian G, Lu Z, et al. The impact of inflammatory burden index on the prognosis in acute decompensated heart failure: evidence from a cohort study in Jiangxi, China. Front Cardiovasc Med 2025; 12: 1604094.
  17. Ge W, Zhang Y, Ge S, et al. Predictive value of IBI for acute kidney injury with contrast after PCI in patients with ST-segment elevation myocardial infarction. Front Cardiovasc Med 2025; 12: 1562731.
  18. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int 2006; 69: S11-5.
  19. Grossman PM, Ali SS, Aronow HD, et al. Contrast‐induced nephropathy in patients undergoing endovascular peripheral vascular intervention: incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Interv Cardiol 2017; 30: 274-80.
  20. Sigterman TA, Krasznai AG, Snoeijs MG, et al. Contrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease. Eur J Vasc Endovasc Surg 2016; 51: 386-93.
  21. Ilis D, Arslan A, Artac I, et al. The predictive value of AGEF score for contrast-induced nephropathy in patients with lower extremity peripheral artery disease. BMC Cardiovasc Disord 2025; 25: 781.
  22. Evsen A, Aktan A, Kılıç R, et al. The predictive value of the CHA2DS2-VASc score in the development of contrast-induced nephropathy after endovascular intervention in peripheral artery disease. Ann Vasc Surg 2025; 116: 17-26.
  23. Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci 2020; 259: 118379.
  24. Azzalini L, Spagnoli V, Ly HQ. Contrast-induced nephropathy: from pathophysiology to preventive strategies. Canadian J Cardiol 2016; 32: 247-55.
  25. Libby P, Loscalzo J, Ridker PM, et al. Inflammation, immunity, and infection in atherothrombosis. J Am Coll Cardiol 2018; 72: 2071-81.
  26. Süleymanoğlu M, Burak C, Gümüşdağ A, et al. Assessment of the relation between C-reactive protein to albumin ratio and the severity and complexity of peripheral arterial disease. Vascular 2020; 28: 731-8.
  27. Süleymanoğlu C, Kidik A, Paçaci E, et al. Naples Score: a novel predictor of infrapopliteal artery disease severity and complexity. Ann Vasc Surg 2026; 123: 410-8.
  28. Aykan AC, Hatem E, Kalaycioglu E, et al. Neutrophil-to-lymphocyte ratio may be a marker of peripheral artery disease complexity. Anatolian J Cardiol 2015; 16: 497-503.
  29. Karaduman A, Balaban İ, Biyiklı K, et al. Relationship of the modified Glasgow Prognostic Score with peripheral artery disease severity and procedure success in patients who had undergone endovascular treatment. Vascular 2025; 33: 410-8.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications